Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD.

Naik, Sachin; Shukla, Shubham; Av, Niranjan; Kumar, Vinod; Sekar, Aravind; Nada, Ritambhra; Rathi, Manish; Kohli, Harbir Singh; Ramachandran, Raja

Naik, Sachin; Shukla, Shubham; Av, Niranjan; Kumar, Vinod; Sekar, Aravind; Nada, Ritambhra; Rathi, Manish; Kohli, Harbir Singh; Ramachandran, Raja.

Affiliation

Naik S; Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Shukla S; Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Av N; Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kumar V; Department of Dermatology, venereology and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sekar A; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Nada R; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Rathi M; Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kohli HS; Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Ramachandran R; Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Kidney Int Rep ; 8(4): 942-943, 2023 Apr.

Article in En | MEDLINE | ID: mdl-37069971

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Kidney Int Rep Year: 2023 Document type: Article Affiliation country: India Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google